Demographics, comorbidities, symptom clusters and 12-month outcome metrics among Therapy Groups (N = 122 PASC patients).</p
<p>Clinical Characteristics and Outcomes of the Grouped Screen-Detected, Prevalence, and Interval Ca...
<p>Number of patients analysed and treatment outcomes at 12 months of ART by cohort on the full data...
<p>Demographic characteristics of the 10,278 patients in the study population by calendar time of tr...
Demographics, stressors, co-morbidities, and 12-month metrics among symptoms clusters (N = 122 patie...
*Proportions reflect a cross-sectional assessment of symptoms during follow-up as baseline measureme...
A. Frequency of post-COVID symptoms lasting ≥ 4 weeks after initial diagnosis as reported by partici...
Group A received few therapeutic interventions; Group B received several interventions, most notably...
Comparison of demographics, comorbid conditions and clinical symptoms of patients in the HPE and AP ...
Patient demographics, mean and median procalcitonin values, frequency of occurrence of comorbid cond...
Symptom Cluster 1 was significantly related to membership in Therapy Group A (Odds Ratio [OR] 2.55, ...
<p>Clinical and demographic characteristics of the study patients summarizing the treatment modaliti...
<p>Sociodemographic Variables, Disease Characteristics for SSc Patients, and Pearson Correlations wi...
Cluster 1 has few symptoms; Cluster 2 has multiple symptoms with high rates of anxiety, depression a...
Patients’ and treatment characteristics and clinical outcomes for overall group and matched group af...
Comparison of demographics, comorbid conditions and clinical symptoms of SFTS patients in the surviv...
<p>Clinical Characteristics and Outcomes of the Grouped Screen-Detected, Prevalence, and Interval Ca...
<p>Number of patients analysed and treatment outcomes at 12 months of ART by cohort on the full data...
<p>Demographic characteristics of the 10,278 patients in the study population by calendar time of tr...
Demographics, stressors, co-morbidities, and 12-month metrics among symptoms clusters (N = 122 patie...
*Proportions reflect a cross-sectional assessment of symptoms during follow-up as baseline measureme...
A. Frequency of post-COVID symptoms lasting ≥ 4 weeks after initial diagnosis as reported by partici...
Group A received few therapeutic interventions; Group B received several interventions, most notably...
Comparison of demographics, comorbid conditions and clinical symptoms of patients in the HPE and AP ...
Patient demographics, mean and median procalcitonin values, frequency of occurrence of comorbid cond...
Symptom Cluster 1 was significantly related to membership in Therapy Group A (Odds Ratio [OR] 2.55, ...
<p>Clinical and demographic characteristics of the study patients summarizing the treatment modaliti...
<p>Sociodemographic Variables, Disease Characteristics for SSc Patients, and Pearson Correlations wi...
Cluster 1 has few symptoms; Cluster 2 has multiple symptoms with high rates of anxiety, depression a...
Patients’ and treatment characteristics and clinical outcomes for overall group and matched group af...
Comparison of demographics, comorbid conditions and clinical symptoms of SFTS patients in the surviv...
<p>Clinical Characteristics and Outcomes of the Grouped Screen-Detected, Prevalence, and Interval Ca...
<p>Number of patients analysed and treatment outcomes at 12 months of ART by cohort on the full data...
<p>Demographic characteristics of the 10,278 patients in the study population by calendar time of tr...